High-dose cisplatin concurrent to concentionally delivered radiotherapy is associated with unacceptable toxicity in unresectable, non-metastatic stage IV head and neck squamous cell carcinoma (2007)
- Autores:
- Autores USP: NADALIN, WLADIMIR - FM ; FERRAZ, ALBERTO ROSSETTI - FM ; FEDERICO, MIRIAM HATSUE HONDA - FM
- Unidade: FM
- DOI: 10.1007/s00405-007-0395-9
- Assuntos: ANTINEOPLÁSICOS (ADMINISTRAÇÃO E DOSAGEM); NEOPLASIAS DE CABEÇA E PESCOÇO (RADIOGRAFIA;RADIOTERAPIA); CARCINOMA DE CÉLULAS ESCAMOSAS (QUIMIOTERAPIA)
- Idioma: Inglês
- Imprenta:
- Local: New Jersey
- Data de publicação: 2007
- Fonte:
- Título do periódico: European Archives of Oto-Rhino-Laryngology and Head & Neck
- ISSN: 0937-4477
- Volume/Número/Paginação/Ano: v. 264, n. 12, p. 1475-1482, december 2007
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
CASTRO JUNIOR, Gilberto de et al. High-dose cisplatin concurrent to concentionally delivered radiotherapy is associated with unacceptable toxicity in unresectable, non-metastatic stage IV head and neck squamous cell carcinoma. European Archives of Oto-Rhino-Laryngology and Head & Neck, v. 264, n. 12, p. 1475-1482, 2007Tradução . . Disponível em: https://doi.org/10.1007/s00405-007-0395-9. Acesso em: 23 abr. 2024. -
APA
Castro Junior, G. de, Snitcovsky, M. L., Gebrim, E. M. M. S., Leitão, G. M., Nadalin, W., Ferraz, A. R., & Federico, M. H. H. (2007). High-dose cisplatin concurrent to concentionally delivered radiotherapy is associated with unacceptable toxicity in unresectable, non-metastatic stage IV head and neck squamous cell carcinoma. European Archives of Oto-Rhino-Laryngology and Head & Neck, 264( 12), 1475-1482. doi:10.1007/s00405-007-0395-9 -
NLM
Castro Junior G de, Snitcovsky ML, Gebrim EMMS, Leitão GM, Nadalin W, Ferraz AR, Federico MHH. High-dose cisplatin concurrent to concentionally delivered radiotherapy is associated with unacceptable toxicity in unresectable, non-metastatic stage IV head and neck squamous cell carcinoma [Internet]. European Archives of Oto-Rhino-Laryngology and Head & Neck. 2007 ; 264( 12): 1475-1482.[citado 2024 abr. 23 ] Available from: https://doi.org/10.1007/s00405-007-0395-9 -
Vancouver
Castro Junior G de, Snitcovsky ML, Gebrim EMMS, Leitão GM, Nadalin W, Ferraz AR, Federico MHH. High-dose cisplatin concurrent to concentionally delivered radiotherapy is associated with unacceptable toxicity in unresectable, non-metastatic stage IV head and neck squamous cell carcinoma [Internet]. European Archives of Oto-Rhino-Laryngology and Head & Neck. 2007 ; 264( 12): 1475-1482.[citado 2024 abr. 23 ] Available from: https://doi.org/10.1007/s00405-007-0395-9 - Predicting relapse in patients submitted to postoperative concurrent chemoradiation for high-risk head and neck squamous cell carcinoma
- Quimiorradioterapia (QRT) concomitante em pacientes portadores de carcinoma espinocelular de cabeça e pescoço (CECCP) não elegiveis para tratamento cirurgico
- Efficacy and safety of concurrent chemoradiotherapy (CCR) for unresectable locally advanced (ULA) head and neck squamous cell carcinoma (HNSCC)
- Quimiorradioterapia concomitante (QRT) em pacientes portadoras de carcinoma epidermóide de cabeça e pescoço (CECCP) localmente avançado, não elegíveis para tratamento cirúrgico
- Patients (pts) with stage IV, non-metastatic advanced head and neck squamous cell carcinoma (HNSCC) submitted to concurrent chemoradiotherapy (CCR)
- Prognostic significance of clinical-pathological features in high-risk head and neck squamous cell carcinoma (HNSCC) patients (pts) treated with postoperative concurrent chemoradiation (CRT)
- High pathologic response rate of neoadjuvant chemoradiation with gemcitabine in locally advanced vulvar carcinoma
- Radioterapia associada a gencitabina no tratamento neoadjuvante do carcinoma vulvar
- ERCC1 protein, mRNA expression, and T19007C polymorphism as prognostic markers in head and neck squamous cell carcinoma (HNSCC) patients treated with surgery and adjuvant cisplatin-based chemoradiation (CRT)
- ERCC1 protein, mRNA expression and T19007C polymorphism as prognostic markers in head and neck squamous cell carcinoma patients treated with surgery and adjuvant cisplatin-based chemoradiation
Informações sobre o DOI: 10.1007/s00405-007-0395-9 (Fonte: oaDOI API)
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
